Literature DB >> 107722

Complete and incomplete Ibc protein fraction in group B streptococci.

L Bevanger, J A Maeland.   

Abstract

The Ibc protein fraction of group B streptococci was isolated from the type Ib strain H36B, the type Ic strain A909, and the type Ic strain 335, and examined against antisera by immunodiffusion and immunoelectrophoresis. The fraction from the Ib strain and one of the Ic strains (A909) contained two antigens or groups of antigens, called the alpha and beta antigens, respectively. Strain 335 produced the alpha but not the beta antigen. This was also the case with three other group B isolates previously classified as type Ic. One type II and one type III strian produced both antigens. The results suggest that group B streptococci producing the Ibc fraction can be subdivided further on the basis of the antigens that are present in that fraction.

Mesh:

Substances:

Year:  1979        PMID: 107722     DOI: 10.1111/j.1699-0463.1979.tb02402.x

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Scand B        ISSN: 0105-0656


  20 in total

1.  Alpha C protein as a carrier for type III capsular polysaccharide and as a protective protein in group B streptococcal vaccines.

Authors:  C Gravekamp; D L Kasper; L C Paoletti; L C Madoff
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Identification of non-immunoglobulin A-Fc-binding forms and low-molecular-weight secreted forms of the group B streptococcal beta antigen.

Authors:  L J Brady; M D Boyle
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

3.  Immunological markers of the R4 protein of Streptococcus agalactiae.

Authors:  Johan A Maeland; Lars Bevanger; Randi Valsoe Lyng
Journal:  Clin Diagn Lab Immunol       Date:  2005-11

4.  Putative novel surface-exposed Streptococcus agalactiae protein frequently expressed by the group B streptococcus from Zimbabwe.

Authors:  Rooyen T Mavenyengwa; Johan A Maeland; Sylvester R Moyo
Journal:  Clin Vaccine Immunol       Date:  2009-07-08

5.  Identification of group B streptococcal Sip protein, which elicits cross-protective immunity.

Authors:  B R Brodeur; M Boyer; I Charlebois; J Hamel; F Couture; C R Rioux; D Martin
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

6.  Nonimmune binding of human immunoglobulin A to type II group B streptococci.

Authors:  B F Anthony; N F Concepcion; S M Puentes; N R Payne
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

7.  Streptococcus agalactiae alpha-like protein 1 possesses both cross-reacting and Alp1-specific epitopes.

Authors:  Augusta I Kvam; Rooyen T Mavenyengwa; Andreas Radtke; Johan A Maeland
Journal:  Clin Vaccine Immunol       Date:  2011-06-08

8.  Variation in repeat number within the alpha C protein of group B streptococci alters antigenicity and protective epitopes.

Authors:  C Gravekamp; D S Horensky; J L Michel; L C Madoff
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

9.  bca, beta gene, and gene product divergency in reference and prototype strains of streptococcus agalactiae.

Authors:  J A Maeland; L Bevanger; G Iversen; R V Lyng
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

10.  Antibodies against Streptococcus agalactiae proteins c(alpha) and R4 in sera from pregnant women from Norway and Zimbabwe.

Authors:  S R Moyo; J A Maeland; J Mudzori
Journal:  Clin Diagn Lab Immunol       Date:  2001-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.